Barx1 Inhibitors
Barx1, a member of the Bar family of homeobox genes, is a transcription factor that plays a pivotal role in embryonic development, particularly in the patterning and differentiation of tissues found in the pharyngeal arches and foregut endoderm. Through its regulation of gene expression, Barx1 orchestrates various developmental processes essential for the formation of structures such as the jaw, teeth, and stomach. Its expression is tightly controlled during embryogenesis, with spatial and temporal patterns dictating its function in tissue specification and morphogenesis. Dysregulation of Barx1 expression has been implicated in developmental abnormalities and diseases, underscoring its significance in embryonic patterning and organogenesis.
Inhibition of Barx1 involves targeting its transcriptional regulation and downstream signaling pathways. Mechanisms of inhibition include interference with transcriptional processes, induction of DNA damage, and modulation of chromatin structure. Small molecules such as Actinomycin D and Mitomycin C exert their inhibitory effects by disrupting transcription and inducing DNA damage, ultimately suppressing Barx1 expression. Additionally, histone deacetylase inhibitors like Trichostatin A contribute to Barx1 inhibition by altering chromatin accessibility at regulatory regions. Understanding the molecular mechanisms underlying Barx1 inhibition provides valuable insights into its role in development and disease pathogenesis, offering avenues for intervention in conditions associated with dysregulated Barx1 expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, a potent RNA synthesis inhibitor, interferes with transcription by binding to DNA, thereby down-regulating Barx1 expression at the transcriptional level. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C, an antitumor antibiotic, crosslinks DNA, leading to DNA damage and activation of DNA damage response pathways, resulting in the inhibition of Barx1 expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin, a HSP90 inhibitor, disrupts HSP90 chaperone function, leading to proteasomal degradation of client proteins, including transcription factors regulating Barx1 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil, a pyrimidine analog, inhibits thymidylate synthase, resulting in the depletion of nucleotide pools and interference with DNA synthesis, leading to Barx1 down-regulation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, a topoisomerase I inhibitor, traps topoisomerase I-DNA cleavage complexes, leading to DNA damage and activation of DNA damage response pathways, inhibiting Barx1 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide, a topoisomerase II inhibitor, induces DNA double-strand breaks, leading to activation of DNA damage response pathways and down-regulation of Barx1 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a platinum-based chemotherapeutic agent, forms intra- and inter-strand DNA crosslinks, leading to DNA damage and activation of DNA repair pathways, suppressing Barx1 expression. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Also called Gemcitabine, this compound is a nucleoside analog, inhibits DNA synthesis and repair processes, leading to accumulation of DNA damage and down-regulation of Barx1 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide, a protein synthesis inhibitor, blocks peptide bond formation during translation, leading to global protein synthesis inhibition and suppression of Barx1 expression. | ||||||